about
Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysisRoles of protease-activated receptors in a mouse model of endotoxemia.Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury.PAR2 absence completely rescues inflammation and ichthyosis caused by altered CAP1/Prss8 expression in mouse skin.Cryptic messages: is noncoagulant tissue factor reserved for cell signaling?Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion.PAR1 contributes to influenza A virus pathogenicity in miceProtease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis.Mast cells regulate myofilament calcium sensitization and heart function after myocardial infarction.Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice.Deregulated matriptase activity in oral squamous cell carcinoma promotes the infiltration of cancer-associated fibroblasts by paracrine activation of protease-activated receptor 2.Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development.Platelet and Erythrocyte Sources of S1P Are Redundant for Vascular Development and Homeostasis, but Both Rendered Essential After Plasma S1P Depletion in Anaphylactic Shock.Sphingosine kinases are not required for inflammatory responses in macrophages.Unchecked thrombin is bad news for troubled arteriesCombined deficiency of protease-activated receptor-4 and fibrinogen recapitulates the hemostatic defect but not the embryonic lethality of prothrombin deficiency.Protease signaling in tumor progression.Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms.Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate.Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells.Platelets and vascular integrity: how platelets prevent bleeding in inflammation.Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition.Endothelial Epas1 Deficiency Is Sufficient To Promote Parietal Epithelial Cell Activation and FSGS in Experimental Hypertension.Endotoxemia rocks sphingolipid metabolism at the blood-brain barrier: An Editorial Highlight for 'Alteration of sphingolipid metabolism as a putative mechanism underlying LPS-induced BBB disruption' on page 172.PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.Activated protein C reverses epigenetically sustained p66 expression in plaque-associated macrophages in diabetesHematopoietic protease nexin-1 protects against lung injury by preventing thrombin signaling in miceOpposite sorting of tissue factor in human umbilical vein endothelial cells and Madin-Darby canine kidney epithelial cellsCoagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 geneSynchronized Ca2+ oscillations induced in Madin Darby canine kidney cells by bradykinin and thrombin but not by ATPProtease-activated receptors 1 and 4 mediate thrombin signaling in endothelial cellsBench to bedside: targeting coagulation and fibrinolysis in acute lung injurySphingosine 1-phosphate-regulated transcriptomes in heterogenous arterial and lymphatic endothelium of the aortaThe tetraspanin CD9 controls migration and proliferation of parietal epithelial cells and glomerular disease progressionMurine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing
P50
Q27335814-BFEE0C7F-3486-4737-BBF9-4665B38EB5BAQ33370039-DEBAB488-9A77-4DD5-AD00-24C06F960878Q34619626-F25EBF47-6A5D-4FDD-9BD8-9634DFE20C3BQ35017558-CA2E745A-1002-4936-B77A-A5CE950A0E44Q35080581-4CAE1EF5-5258-4202-A28B-4814BA8AD007Q36121784-47F95F48-5F45-4EF4-832A-EE3D85971D6AQ36497143-34B751C3-074E-4354-91FD-5E36966CFA2CQ36631311-BEC14594-6D21-4979-83FC-EBF116BF1DC0Q37047339-E465D6E3-EA31-4C73-8684-91E24375E8A8Q37241418-F20BD55E-DD25-43F5-889E-20DC77FE9D7AQ38746986-E03D7C55-B27E-4AAD-B107-D16E69CBCB83Q41290741-ACB65684-F79A-4F3E-A4C6-A07DC1F68D90Q41659266-021EFF0D-F750-4A80-8C66-CC517D8B0B15Q42736013-C6607C21-102B-48DA-A33F-3BD894E63871Q42772295-7060B14E-BBC8-4064-A16D-CD51CE1E524CQ43751452-EC56DF5C-F639-4E63-AF8C-AAA6961CD2ECQ46251817-B2A1A033-8AF7-489E-96BA-7E56DCEC06ADQ46253083-993A0BB6-5B6E-4D7C-86AE-9C5B5F707402Q46494392-A626913E-75E4-4A12-AD20-76229E34B9CFQ46882509-783687BA-310F-402D-A919-F2D1A773D33DQ47297561-D4A294B2-E841-4534-810B-2665CE59E61DQ47350943-CC2E2A42-BD23-490C-BEC6-9E4DB7F81CAAQ47776165-6CE60269-6F6C-4DCA-BDE4-6D9746FDBC9AQ47891599-5E5BA5B7-BD7C-4A64-BDCD-CF63D92F8BE1Q52723151-B423AFDE-8482-4E38-A369-5D45DF3AAAD6Q57134943-110CC97A-D9A7-4541-9519-F50739A5A49CQ58698399-990E2D9C-1B5E-4C93-BEE1-C6035ECE217BQ71228925-7CE56815-855D-49C9-95AF-C68ABE198513Q73133785-9D036620-7C85-410C-B1F0-BB76CCF5250CQ73229715-9D2BE06B-109D-4744-8B5A-B3D8B7F07470Q73686895-401FB9C9-4FCF-418A-95B8-D375C624ACB3Q83221910-ACD425E1-F8AF-4465-A2FE-D280BF8539BAQ89855423-54225EE1-CA4D-48F8-B753-A248300AB8CBQ92153518-9593795F-76D2-4699-AD88-03D7B2E8F1F1Q92570553-81B22E4A-BC24-4BC8-BD55-5DE29BB96985
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Eric Camerer
@ast
Eric Camerer
@en
Eric Camerer
@es
Eric Camerer
@nl
Eric Camerer
@sl
type
label
Eric Camerer
@ast
Eric Camerer
@en
Eric Camerer
@es
Eric Camerer
@nl
Eric Camerer
@sl
prefLabel
Eric Camerer
@ast
Eric Camerer
@en
Eric Camerer
@es
Eric Camerer
@nl
Eric Camerer
@sl
P106
P21
P31
P496
0000-0002-6271-7125